PERKii ranked 18 in the Smart50 Awards

December 09, 2021 1 min read

PERKii ranked 18 in the Smart50 Awards

The Awards

Since its very beginning, back in 2007, the Smart50 Awards have recognised and celebrated the fastest growing SMEs in Australia and we’re excited to bring the awards back this year.

Each year, the Smart50 finalists represent the very best of Australian business. They are the innovators and the job creators, the hard-working community heroes.

These businesses have never been more important to our country as we all face the enormous challenge of surviving and recovering from the COVID-19 pandemic.

How it started

Researchers at the University of Queensland developed a way to protect probiotics from the acidity of the digestive system, allowing them to reach the gut where they become most effective.

Commercialised as ProGel, the breakthrough was used by founder Cameron Turner to create PERKii, a probiotic drink that is now available in Australia and New Zealand.

Growth

Since bringing the probiotic breakthrough to a consumer-relevant product, PERKii has expanded its market footprint dramatically. The drink can now be purchased at 10,000 locations, including a range of both Coles and Woolworths stores.

Over the past three financial years, the business has seen stellar growth, increasing revenue from $1.1 million for the 2018-19 financial year to $3.2 million in 2020-21.

Where to next?

Now PERKii has achieved commercial proof of concept in the local market, Turner’s goal is to replicate that success globally in the next two to three years.

That will likely come through either a sale or a significant distribution arrangement, turning the lab breakthrough into an international commercial success.



Also in News

Workzone West leads the way in WA
Workzone West leads the way in WA

March 03, 2022 2 min read

THE Workzone West building at 202 Pier Street in the Perth CBD is now the first carbon neutral 6 Star NABERS Energy rated commercial building in Western Australia.
ENA Respiratory and the COPD Foundation Partner to Develop Pan-Antiviral Nasal Spray
ENA Respiratory and the COPD Foundation Partner to Develop Pan-Antiviral Nasal Spray

February 24, 2022 3 min read

INNA-051 is being developed to stimulate innate immunity and reduce the incidence and severity of respiratory viral infections, such as COVID-19, rhinovirus, or influenza in populations at-risk of complications that include individuals with COPD
Perennial, Arbel double down on SME lender Lumi
Perennial, Arbel double down on SME lender Lumi

February 21, 2022 2 min read

Only two months since it closed a $20 million round, SME lender Lumi has raised another $10 million, thanks to the growth of its loan book drastically exceeding its forecasts.